Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 10/20 | 0.59 |
| ▸ | CA2 | P00918 | 10/20 | 0.59 |
| ▸ | CA9 | Q16790 | 8/20 | 0.59 |
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.59 |
| ▸ | CA3 | P07451 | 2/20 | 0.59 |
| ▸ | CA4 | P22748 | 2/20 | 0.59 |
| ▸ | CA6 | P23280 | 2/20 | 0.59 |
| ▸ | CA5A | P35218 | 2/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.59 |
| ▸ | RECQL | P46063 | 2/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL285164 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL11143885 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL30442 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL9745435 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL11212246 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL9745429 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Octadecyl Sulfate SCHEMBL7532328 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL23132 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL339361 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL1191484 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037902-A | Reservoir repair-shaft cleaning integrated agent for natural gas well and preparation method thereof | 西安石油大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122055130-A | Method for caring for and/or making up skin | 莱雅公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4734945-A1 | WASH COMPOSITION WITH ANIONIC SULFATE AND SULTAINE NOT RELIANT ON PALM KERNEL OIL | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| WO-2025102255-A1 | PROCESS FOR CARING FOR AND/OR MAKING UP THE SKIN | L'OREAL (FR) | 2025-05-22 | — | — | WO | claimed |
| CN-119757505-A | Method for detecting NGF purity by SHS capillary gel electrophoresis | 上海甲贝医药科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| WO-2025002874-A1 | WASH COMPOSITION WITH ANIONIC SULFATE AND SULTAINE NOT RELIANT ON PALM KERNEL OIL | UNILEVER IP HOLDINGS B.V. (NL) | 2025-01-02 | — | — | WO | claimed |
| CN-118530665-A | A composition methods of use of the compositions | 华为技术有限公司 | 2024-08-23 | — | — | CN | claimed |
| US-20240131103-A1 | NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS | NOKHA TRADING LLP (IN) | 2024-04-25 | — | — | US | claimed |
| EP-4294418-A1 | NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS | Lyrus Life Sciences Pvt. LTD. (IN) | 2023-12-27 | — | — | EP | claimed |
| CN-116762808-A | Concentrated acidic phenol disinfectant and preparation method thereof | 山东利尔康医疗科技股份有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-102015778-A | Shear thinning peroxide dispersions | ARKEMA INC | 2011-04-13 | — | — | CN | claimed |
| EP-2271677-A1 | SHEAR THINNING PEROXIDE DISPERSIONS | Arkema Inc. (US) | 2011-01-12 | — | — | EP | claimed |
| WO-2009134950-A1 | SHEAR THINNING PEROXIDE DISPERSIONS | ARKEMA INC. (US) | 2009-11-05 | — | — | WO | claimed |
| EP-0896524-B1 | TOPICAL COMPOSITIONS COMPRISING DISPERSED SURFACTANT COMPLEX | PROCTER & GAMBLE (US) | 2003-07-09 | — | — | EP | claimed |
| CN-1221336-A | Topical compositions comprising dispersed surfactant complexes | PROCTER & GAMBLE (US) | 1999-06-30 | — | — | CN | claimed |
| CN-1221335-A | Topical compositions comprising dispersed surfactant complex | PROCTER & GAMBLE (US) | 1999-06-30 | — | — | CN | claimed |
| EP-0901369-A1 | TOPICAL COMPOSITIONS COMPRISING DISPERSED SURFACTANT COMPLEX | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-17 | — | — | EP | claimed |
| EP-0896524-A1 | TOPICAL COMPOSITIONS COMPRISING DISPERSED SURFACTANT COMPLEX | THE PROCTER & GAMBLE COMPANY (US) | 1999-02-17 | — | — | EP | claimed |
| WO-1997040817-A1 | TOPICAL COMPOSITIONS COMPRISING DISPERSED SURFACTANT COMPLEX | THE PROCTER & GAMBLE COMPANY (US) | 1997-11-06 | — | — | WO | claimed |
| WO-1997040816-A1 | TOPICAL COMPOSITIONS COMPRISING DISPERSED SURFACTANT COMPLEX | THE PROCTER & GAMBLE COMPANY (US) | 1997-11-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131103-A1 | NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS | C5, BSG, C1S | CA1 3205/4885CA2 1994/4885CA9 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.